Trial Profile

A Phase II Trial on the Safety and Efficacy of C1 Inhibitor for the Acute Management of Severe Traumatic Brain Injury

Status: Active, no longer recruiting

Phase of Trial: Phase II

Latest Information Update: 24 Aug 2026

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Complement C1 inhibitor protein (Primary) ; Sodium chloride
Indications Traumatic brain injuries
Focus Adverse reactions; Therapeutic Use
Acronyms CIAO@TBI

Most Recent Events

13 Jul 2026 Status changed from recruiting to active, no longer recruiting.
04 Dec 2021 Trial design has been released in the Trials
06 Sep 2021 Planned End Date changed from 1 Dec 2023 to 1 Jul 2024.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com